Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
TME Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

€0.2

2024-05-23

Market Capitalization

€6.9 M

2024-05-23

CreditSafe Score

?
Score changed on May 30, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

EURFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022
Gross profit378.0K279.0K147.0K82.0K34.0K
Operating expense total4.7M4.2M5.8M13.5M11.9M
Depreciation and amortization23.0K47.0K62.0K67.0K92.0K
EBITDA(4.3M)(3.9M)(5.7M)(13.4M)(11.9M)
EBIT(4.3M)(3.9M)(5.8M)(13.5M)(12.0M)
Interest income388.0K
Interest expense6.8M3.0K5.1M1.5M3.4M
Pre tax profit(10.7M)(860.0K)(10.4M)(14.5M)(15.1M)
Income tax expense1.0K1.0K1.0K7.0K
Net Income(10.7M)(861.0K)(10.4M)(14.5M)(15.1M)

Footer menu